CLINICAL-TRIALS WITH THE HEXITOL DERIVATIVES IN THE UNITED-STATES

被引：0
作者：
CHIUTEN, DF
ROZENCWEIG, M
VONHOFF, DD
MUGGIA, FM
机构：
[1] NCI,PROGRAM CLIN ONCOL,BETHESDA,MD 20205
[2] NCI,PEDIAT ONCOL BRANCH,BETHESDA,MD 20205
来源：
CANCER | 1981年 / 47卷 / 03期
关键词：
D O I：
10.1002/1097-0142(19810201)47:3<442::AID-CNCR2820470304>3.0.CO;2-1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：442 / 451
页数：10
相关论文
共 70 条
  • [61] THIGPEN JT, 1979, CANCER TREAT REP, V63, P553
  • [62] THIGPEN JT, 1979, CANCER TREAT REP, V63, P525
  • [63] TORMEY DC, 1978, P AM ASSOC CANC RES, V19, P34
  • [64] TORMEY DC, 1976, CANCER TREAT REP, V60, P1593
  • [65] TORMEY DC, 1977, CANCER RES, V37, P529
  • [66] VANAMBURG AL, 1979, CANCER TREAT REP, V63, P141
  • [67] VARGHA L, 1957, J CHEM SOC C, V151, P805
  • [68] VOGEL CL, 1976, CANCER TREAT REP, V60, P895
  • [69] PHASE 3 STUDY IN LUNG CARCINOMA COMPARING HEXAMETHYLMELAMINE (NSC 13875) TO DIBROMODULCITOL (NSC 104800)
    WILSON, WL
    VANRYZIN, J
    WEISS, AJ
    FRELICK, RW
    MOSS, SE
    [J]. ONCOLOGY, 1975, 31 (5-6) : 293 - 309
  • [70] 1973, EUR J CANCER, V9, P583
1234567